H.A. Verbrugh

1.4k total citations
21 papers, 1.1k citations indexed

About

H.A. Verbrugh is a scholar working on Infectious Diseases, Epidemiology and Clinical Biochemistry. According to data from OpenAlex, H.A. Verbrugh has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Clinical Biochemistry. Recurrent topics in H.A. Verbrugh's work include Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (4 papers). H.A. Verbrugh is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers) and Antibiotic Resistance in Bacteria (4 papers). H.A. Verbrugh collaborates with scholars based in Netherlands, United States and France. H.A. Verbrugh's co-authors include Alex van Belkum, Jan Nouwen, Hélène Boelens, Martine De Vos, Marjolein Kluytmans-van den Bergh, Amy Hofman, Alewijn Ott, Heiman Wertheim, A.F. vanBelkum and Damian C. Melles∗ and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and Kidney International.

In The Last Decade

H.A. Verbrugh

21 papers receiving 1.0k citations

Peers

Countries citing papers authored by H.A. Verbrugh

Since Specialization

Citations

This map shows the geographic impact of H.A. Verbrugh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.A. Verbrugh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.A. Verbrugh more than expected).

Fields of papers citing papers by H.A. Verbrugh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.A. Verbrugh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.A. Verbrugh. The network helps show where H.A. Verbrugh may publish in the future.

Co-authorship network of co-authors of H.A. Verbrugh

This figure shows the co-authorship network connecting the top 25 collaborators of H.A. Verbrugh. A scholar is included among the top collaborators of H.A. Verbrugh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.A. Verbrugh. H.A. Verbrugh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Frequency of Microbiologically Correct Antibiotic Therapy Increased by Infectious Disease Consultations and Microbiological Results 2012 ·Journal of Clinical Microbiology ·J. J. Kerremans, H.A. Verbrugh, Martine De Vos	24
2	Co-evolutionary aspects of human colonisation and infection by Staphylococcus aureus 2008 ·Infection Genetics and Evolution ·A.F. vanBelkum, Damian C. Melles∗, Jan Nouwen, (unknown), (unknown), Martine De Vos, Heiman Wertheim, H.A. Verbrugh	198
3	[Research priorities of the MRSA problem in the Dutch animal husbandry]. 2006 ·PubMed ·Dik Mevius, H.A. Verbrugh	1
4	Predicting the Staphylococcus aureus Nasal Carrier State: Derivation and Validation of a "Culture Rule" 2004 ·Clinical Infectious Diseases ·Jan Nouwen, Alewijn Ott, Marjolein Kluytmans-van den Bergh, Hélène Boelens, Amy Hofman, Alex van Belkum, H.A. Verbrugh	190
5	Multilocus sequence typing of Staphylococcus aureus with DNA array technology 2003 ·(unknown), Corinne Jay, Susan V. Snijders, (unknown), Bruno Lacroix, H.A. Verbrugh, Mark C. Enright, Alain Troesch, A.F. vanBelkum	2
6	Comparative evaluation of three chromogenic agars for detection and rapid identification of aerobic Gram-negative bacteria in the normal intestinal microflora 2003 ·Clinical Microbiology and Infection ·P. Margreet G. Filius, (unknown), (unknown), Arnold G. Vulto, Inge C. Gyssens, H.A. Verbrugh, Hubert P. Endtz	18
7	Heterogeneity among infecting strains of Pseudomonas aeruginosa in diverse departments of a large Tunisian hospital 2001 ·Journal of Hospital Infection ·Karim Ben Slama, Abdellatif Boudabous, (unknown), (unknown), (unknown), (unknown), Janneke J. Maaskant, H.A. Verbrugh, Alex van Belkum	7
8	Assessment of the effectiveness, safety, and biocompatibility of icodextrin in automated peritoneal dialysis. The Dextrin in APD in Amsterdam (DIANA) Group. 2000 ·PubMed ·N Posthuma, Piet M. ter Wee, (unknown), P. L. Oe, Elizabeth Peers, H.A. Verbrugh	45
9	Application of Pulsed-Field Gel Electrophoresis and Binary Typing as Tools in Veterinary Clinical Microbiology and Molecular Epidemiologic Analysis of Bovine and HumanStaphylococcus aureusIsolates 2000 ·Journal of Clinical Microbiology ·Ruth N. Zadoks, Willem van Leeuwen, Herman W. Barkema, O.C. Sampimon, H.A. Verbrugh, Y.H. Schukken, Alex van Belkum	128
10	Transmission of hepatitis B virus among heart transplant recipients during endomyocardial biopsy procedures. 1998 ·PubMed ·Albert D. M. E. Osterhaus, Martine De Vos, Aggie H.M.M. Balk, Robert A. de Man, Johan W. Mouton, P H Rothbarth, Solko W. Schalm, (unknown), Hubert G.M. Niesters, H.A. Verbrugh	27
11	Exchange of Pseudomonas aeruginosa strains among cystic fibrosis siblings 1997 ·Research in Microbiology ·Nicole H. M. Renders, M. Sijmons, Alex van Belkum, Shelley E. Overbeek, Johan W. Mouton, H.A. Verbrugh	30
12	Molecular Typing of Cryptococcus neoformans: Taxonomic and Epidemiological Aspects 1997 ·International Journal of Systematic Bacteriology ·Teun Boekhout, Alex van Belkum, Alexander C. A. P. Leenders, H.A. Verbrugh, (unknown), D. Swinne, W. A. Scheffers	83
13	Comparative in-vitro activity of meropenem against selected pathogens from hospitalized patients in The Netherlands. MASTIN Study Group 1997 ·Journal of Antimicrobial Chemotherapy ·Hubert P. Endtz, Willemien C. van Dijk, H.A. Verbrugh	8
14	Molecular epidemiology: what the epidemiologist needs to know 1997 ·Current Opinion in Infectious Diseases ·Alex van Belkum, H.A. Verbrugh	2
15	APACHE II for Predicting Course and Outcome of Nosocomial Staphylococcus aureus Bacteremia and Its Relation to Host Defense 1996 ·The Journal of Infectious Diseases ·Ed P. F. Yzerman, Hélène Boelens, Jeroen H. T. Tjhie, Jan Kluytmans, Johan W. Mouton, H.A. Verbrugh	46
16	PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice 1996 ·Journal of Clinical Microbiology ·(unknown), Wil H. F. Goessens, Alex van Belkum, (unknown), Hans van Vliet, H.A. Verbrugh	22
17	Liposomal amphotericin B (AmBisome) reduces dissemination of infection ad compared with amphotericin B deoxycholate (Fungizone) in a rat model of pulmonary aspergillosis 1996 ·Journal of Antimicrobial Chemotherapy ·Alexander C. A. P. Leenders, S. de Marie, M. T. ten Kate, Irma A. J. M. Bakker‐Woudenberg, H.A. Verbrugh	61
18	Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis 1992 ·Kidney International ·Carola W.H. de Fijter, H.A. Verbrugh, Liem P. Oe, Edith Peters, Jan van der Meulen, A. J. M. Donker, J. Verhoef	45
19	Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. 1982 ·BMJ ·B. Sweder van Asbeck, H.A. Verbrugh, Bernard A. van Oost, J. J. M. Marx, (unknown), J. Verhoef	82
20	GROUP DISCUSSIONS AND STUDENT TUTORS IN A PRECLINICAL PATHOLOGY COURSE 1971 ·The Lancet ·H.A. Verbrugh	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact